Does MOGAMULIZUMAB Cause Disease progression? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Disease progression have been filed in association with MOGAMULIZUMAB (POTELIGEO). This represents 10.4% of all adverse event reports for MOGAMULIZUMAB.
46
Reports of Disease progression with MOGAMULIZUMAB
10.4%
of all MOGAMULIZUMAB reports
22
Deaths
20
Hospitalizations
How Dangerous Is Disease progression From MOGAMULIZUMAB?
Of the 46 reports, 22 (47.8%) resulted in death, 20 (43.5%) required hospitalization, and 4 (8.7%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOGAMULIZUMAB. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does MOGAMULIZUMAB Cause?
Rash (59)
Infusion related reaction (42)
Pyrexia (35)
Febrile neutropenia (29)
Erythema (28)
Pruritus (26)
Drug ineffective (24)
Constipation (22)
Death (21)
Insomnia (21)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which MOGAMULIZUMAB Alternatives Have Lower Disease progression Risk?
MOGAMULIZUMAB vs MOGAMULIZUMAB-KPKC
MOGAMULIZUMAB vs MOLNUPIRAVIR
MOGAMULIZUMAB vs MOLSIDOMINE
MOGAMULIZUMAB vs MOMELOTINIB
MOGAMULIZUMAB vs MOMETASONE